ADM stops producing dry lysine in the first half of next year
ADM recently announced that it will stop producing dry lysine in the first half of 2021, focusing on meeting the market's demand for liquid and capsule lysine.
In addition, the company also plans to launch new differentiated solutions for dairy cows, including NutriPass L, a capsule lysine product that can continuously supply metabolic lysine to animals.
Pierre Joseph Paoli, President of ADM's Feed Ingredients and Additives Business, pointed out: "The market prospects for dry lysine are already quite bleak, and the global industry capacity expansion far exceeds the growth rate of demand. We will continue to invest to provide customers with cutting-edge raw materials and services, while continuing to consolidate And to strengthen the animal nutrition business product portfolio."
2026-10-09
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
U.S. Finds Methionine Dumping Could Recur, With Japan Margin Up to 76.50%
-
U.S. Finds Methionine Dumping Could Recur, With Japan Margin Up to 76.50%
-
U.S. Formally Imposes Antidumping and Countervailing Duty Orders on Chinese L-Lysine
-
VIV Africa 2026: A Look at Who's Coming to Kigali
-
VIV Health & Nutrition Asia 2026 Brings Together Innovation and Business Across the Animal Feed and Health Industry
-
Can ADM's Acquisition of Revela Foods Transform Its Global Flavors Portfolio?
-
European Commission Greenlights Innovative Feed Additives for Livestock Nutrition
-
EU Declares Safety of Nematophilic Fungus NCIMB 30336 Feed Additive for Herbivores
-
EU Greenlights Corynebacterium glutamicum KCCM 80185-Derived L-Isoleucine as Universal Animal Feed Supplement
-
Study found that Lactobacillus rhamnosus GCC-3 culture can improve intestinal and liver health and antiviral immunity of zebrafish
Recommend Reading
-
DyStar Becomes a Wholly-Owned Subsidiary of Zhejiang Longsheng Group, Ending Longstanding Shareholder Disputes with a $5 Billion Deal
-
A Cold-Chain Crackdown in Delhi Sends a Much Bigger Message
-
China’s Approval of Pfizer’s GLP-1 Drug Signals a Sharper Obesity Race
-
Dow and Celanese Retreat: European and Korean Cutbacks as China Expands
-
Toray to Transfer Stake in Soda Aromatic to Samyang
-
Premium Global Chemical Sourcing Requests (29 Dec, 2025- 2 Jan, 2026)
-
Chemical Reactions and Uses of Stilbene
-
Uses of Dithiothreitol in Laboratories
-
Supporting Each Other | ECHEMI Employees Voluntarily Raise Funds for Flood Relief in Southern Thailand
-
Premium Global Chemical Sourcing Requests (16-19July, 2026)